Amalgamated Bank Standard Biotools Inc. Transaction History
Amalgamated Bank
- $12.2 Billion
- Q4 2024
A detailed history of Amalgamated Bank transactions in Standard Biotools Inc. stock. As of the latest transaction made, Amalgamated Bank holds 10,438 shares of LAB stock, worth $12,108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,438
Previous 10,438
-0.0%
Holding current value
$12,108
Previous $20,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding LAB
# of Institutions
143Shares Held
274MCall Options Held
6.7KPut Options Held
48.7K-
Casdin Capital, LLC New York, NY71.3MShares$82.7 Million10.73% of portfolio
-
Viking Global Investors LP58.7MShares$68 Million0.35% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$25.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$19.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY16.9MShares$19.5 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $91.2M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...